Story
Ancora Lifts Offer for H.B. Fuller's Adhesives Unit to $1.4 Billion, Bloomberg Reports

Summary
Activist investor Ancora Holdings has reportedly raised its unsolicited cash bid for H.B. Fuller's building adhesives division to $1.4 billion, increasing pressure on the chemical maker's board after an initial rejection.
Activist investor Ancora Holdings Group has increased its unsolicited cash offer for H.B. Fuller's (NYSE:FUL) building adhesives unit to as much as $1.4 billion, escalating pressure on the chemical company's board, according to a report from Bloomberg News. The revised proposal aims to bring H.B. Fuller's directors to the negotiating table after they rejected an earlier bid.
Details of the Increased Bid
The new offer represents a $200 million increase at the upper end of Ancora's previous proposal, which ranged from $1.1 billion to $1.2 billion. To underscore the bid's credibility and viability, Ancora has reportedly secured a highly confident letter for debt financing from Fortress Investment Group.
Ancora is pushing for a carve-out of what it considers a lower-margin division. The activist investor argues that a sale would unlock significant value for H.B. Fuller shareholders.
Strategic Rationale and Board's Position
The Cleveland-based activist firm contends that divesting the segment would allow H.B. Fuller to:
Ad- Significantly pay down debt on its balance sheet.
- Sharpen management's focus on its core specialty chemical operations.
- Better integrate its recent acquisition of UK-based Advanced Medical Solutions Group Plc.
H.B. Fuller's board previously rebuffed Ancora’s initial approach, stating that the offer materially undervalued the business unit and its long-term growth potential. The board also cited a lack of execution details in its rejection.
Context and Market Reaction
The sweetened bid is the latest move in a campaign that began in May, when Ancora publicly criticized H.B. Fuller's acquisition of Advanced Medical Solutions as "risky and value-destructive." Ancora, which has a history of high-profile campaigns at companies like Norfolk Southern Corp., has warned it may pursue legal remedies if it believes the board is harming shareholder value.
Market reaction to the updated offer was subdued. According to the report, shares of H.B. Fuller dipped less than 1% in premarket trading on Tuesday.
Read next
More on Stocks
Praxis Options See Large Bullish Bet Ahead of Two FDA Decisions
A significant options trade on Praxis Precision Medicines suggests a trader is positioning for a substantial stock move ahead of two key FDA drug approval decisions slated for late 2026 and early 2027.

General Mills Appoints COO Dana McNabb as CEO to Succeed Jeff Harmening
The consumer goods company named 27-year veteran Dana McNabb its next chief executive, effective Jan. 1, as it navigates high inflation and competition from private-label brands.

Helsinki Benchmark Index Slips on Industrial and Financial Sector Weakness
Finland's OMX Helsinki 25 index closed down 0.55% on Wednesday, dragged lower by losses in the telecommunications, industrial, and financial sectors.

BEL 20 Index Falls to One-Month Low on Sector-Wide Weakness
Belgium's benchmark BEL 20 index fell 0.73% on Wednesday, hitting a new one-month low. The decline was driven by losses in the technology, financials, and consumer goods sectors, with Warehouses de Pauw NV leading the laggards.